SLS SELLAS LIFE SCIENCES GROUP INC Investments/Divestments 8-K Filing 2024 - Securities Purchase Agreement for Registered Direct Offering SELLAS Life Sciences Group, Inc. entered into a Securities Purchase Agreement with institutional investors for a registered direct offering, issuing shares of common stock and pre-funded warrants, with expected gross proceeds of $20.0 million.Get access to all SEC 8-K filings of the SELLAS LIFE SCIENCES GROUP INC